News
Hosted on MSN24d
Pfizer targets $7.7B in operational efficiency savings by 2027, highlights strategic R&D shiftsAnalyst Trung Huynh from UBS asked about potential ACIP policy changes ... s focus on operational efficiency, capital allocation, and strategic R&D shifts positions Pfizer to navigate ...
23d
Despite a 6% revenue drop, Pfizer Inc (PFE) focuses on R&D advancements, cost savings, and dividend growth to drive future success.
risks related to the successful integration of the licensed asset with Pfizer’s business; disruption from the transaction making it more difficult to maintain business and operational ...
Other changes at Pfizer include Mikael Dolsten ... He will also cover business analytics, global commercial operations and patient and health impact, among others. Pfizer’s Consumer Healthcare ...
And the key policy change impacts on Pfizer was a reduced ability to raise ... opportunities to drive improvements in productivity and operational efficiency in our R&D organization, again ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback